Search results
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 5 days agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
Invivyd appoints two new directors to its board By Investing.com
Investing.com· 6 days agoInvivyd Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced the election of two new...
New study provides the "definitive answer on masks." They work
Boing Boing· 4 days agoIn schools, masks did help, but not as much as improving air circulation in the classrooms did. Note that the ventilation improvement that’s described in that citation was for better air circulation ...
Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted...
Nutraingredients.com· 2 days agoNumerous studies have shown how the coronavirus infection can cause medium and long-term effects, generally known as “chronic COVID syndrome” or “Long-COVID”. One of the most common symptoms ...
California Supreme Court Sides With Insurer in COVID-19 Loss Case | The Recorder
Law.com· 5 days agoThe presence of the COVID-19 virus at a business does not automatically trigger insurance loss coverage, even if the establishment was forced to close, the California Supreme Court held Thursday ...
New study provides the "definitive answer on masks." They work.
Boing Boing· 4 days agoThe paper, which is based on a narrative review and meta-analysis research project, was written by...
CureVac (NASDAQ:CVAC) Sees Large Volume Increase
ETF DAILY NEWS· 4 days agoShares of CureVac (NASDAQ:CVAC – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 290,327 shares traded hands during mid-day trading, a decline of 63% from the ...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
Morningstar· 5 days agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
KTLA-TV Los Angeles· 5 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
KTLA-TV Los Angeles· 4 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...